RenovoRx (RNXT) vs Xilio Therapeutics (XLO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
RenovoRx (RNXT) has outperformed Xilio Therapeutics (XLO) over the past year, gaining 12.3% versus a loss of 21.7%. RenovoRx is the larger company by market cap ($61.8 million vs $59.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | RNXT | XLO |
|---|---|---|
| Share price | $1.37 | $9.01 |
| Market cap | $61.83M | $59.29M |
| 1-day change | -1.44% | +0.11% |
| YTD return | +63.10% | +0.56% |
| 1-year return | +12.30% | -21.71% |
| 5-year return | -77.09% | — |
| EPS (TTM) | $-0.31 | $-0.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.59 | $12.59 |
| 52-week low | $0.701 | $6.47 |
| Distance from 52-week high | -47.10% | -28.41% |
| Average volume | 753.57K | 20.06K |
| Shares outstanding | 45.13M | 6.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RNXT has outperformed XLO by 34.0 percentage points over the past year.
RNXT vs XLO FAQ
Which is bigger, RenovoRx or Xilio Therapeutics?
RenovoRx (RNXT) is larger, with a market capitalization of $61.83M compared with $59.29M for Xilio Therapeutics (XLO).
Which stock has performed better over the past year, RNXT or XLO?
RNXT returned +12.30% over the past 12 months, compared with -21.71% for XLO (price return, excluding dividends). Past performance does not predict future results.
Are RenovoRx and Xilio Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.